Cadila Pharma names Ashraf Allam as Global COO

19 December 2022 | News

An energetic entrepreneur, global business leader, and strategic thinker

Ahmedabad-based Cadila Pharmaceuticals has appointed Ashraf Allam as the Global Chief Operating Officer (COO). Allam joined Cadila Pharma on November 30, 2022. He will be based at Bhat corporate office and will report to Cadila’s Group Chairman and Managing Director Dr Rajiv Modi.

An accomplished and well-regarded industry leader with more than three decades of experience, Allam was serving recently as the Chief Executive Officer (CEO) at the Public Investment Fund prior to joining Cadila Pharmaceuticals.

He also serves as a board member for a number of US, European and regional Pharma, Biotech, Medical devices, Diagnostics, Self-medication and technology companies. In addition, he is also serving as senior executive advisor for global private equity funds and family offices both in the US, Europe and in the Middle East.

Allam has a strong track record of holding senior positions at global multinational and privately-held companies such as Johnson & Johnson, Amgen, Eli Lilly, BMS and Mundipharma. He brings a great mix of leadership, inspiration, operational experience, technical breadth, and passion for patients.

An energetic entrepreneur, global business leader, and strategic thinker, Allam has deep knowledge and extensive experience in building and managing businesses in the healthcare Industry. His ability to drive growth of people and businesses, build brands, transform operations, scale-up capabilities, and successful corporate acquisitions and alliances have been the hallmark of his successful track record.



× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account